Le PIIINP dans le diagnostic de l`hypersomatotropisme et le suivi de

ENDOCRINOLOGIE FÉLINE
Références
Magali Decome
Faculté de médecine vétérinaire
3200, rue Sicotte
Service de médecine interne
Saint-Hyacinthe
J25 2M2 Canada
Le PIIINP dans
le diagnostic de
l’hypersomatotropisme
et le suivi de la réponse
au traitement chez le chat
diabétique
1. Berg RIM, Nelson RW,
Feldman EC et coll. Serum
insulin-like growth factor-I
concentration in cats with
diabetes mellitus and
acromegaly. J. Vet. Intern.
Med. 2007;21:892-898.
2. Dominici FP, Argentino DP,
Muñoz MC et coll. Influence
of the crosstalk between
growth hormone and insulin
signalling on the modulation
of insulin sensitivity. Growth
Horm. IGF Res. 2005;15:
324-336.
3. Greco DS. Feline
acromegaly. Top Comp.
Anim. Med. 2012;27:31-35.
4. Jensen KB, Forcada Y,
Church DB et coll. Evaluation
and diagnostic potential
of serum ghrelin in feline
hypersomatotropism and
diabetes mellitus. J. Vet.
Intern. Med. 2015;29:14-20.
XVe ed. Elsevier, St. Louis,
Missouri. 2014:216-221.
5. Keyte SV, Kenny PJ,
Forcada Y et coll. Serum
N-terminal type III
procollagen propeptide:
An indicator of growth
hormone excess and
response to treatment in
feline hypersomatotropism.
J. Vet. Intern. Med.
2016;30:973-982.
8. Niessen SJM. Feline
acromegaly: An essential
differential diagnosis for the
difficult diabetic. J. Feline
Med. Surg. 2010;12:15-23.
6. Myers JA, Lunn KF,
Bright JM. Echocardiographic
findings in 11 cats with
acromegaly. J. Vet. Intern.
Med. 2014;28:1235-1238.
7. Niessen SJM, Church DB.
Feline hypersomatotropism
and acromegaly. In:
Bonagura JD, Twedt DC, eds.
Current Veterinary Therapy.
9. Niessen SJM,
Church DB, Forcada Y.
Hypersomatotropism,
acromegaly, and
hyperadrenocorticism and
feline diabetes mellitus. Vet.
Clin. North Am. Small Anim.
Pract. 2013;43:319-350.
10. Reusch CE. Disorders
of growth hormone.
In: Feldman EC, Nelson
RW, Reusch CE et coll.,
eds. Canine & feline
endocrinology. 4th ed.
Elsevier, St. Louis, Missouri.
2015:37-76.